These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Visceral leishmaniasis with portal hypertension mimicking auto immune hepatitis. Bouyahia O; Khelifi I; Ben Mansour F; Khaldi F Med Mal Infect; 2007 Dec; 37 Suppl 3():S268-9. PubMed ID: 18037255 [No Abstract] [Full Text] [Related]
7. [Unusual infectious diseases in a municipal hospital (author's transl)]. Biller H; Moll A; Wandt H MMW Munch Med Wochenschr; 1976 Nov; 118(45):1457-60. PubMed ID: 825760 [TBL] [Abstract][Full Text] [Related]
8. [Kala-azar in Mexico: report of 2 cases]. Trejo-Pérez JA; Miranda-Novales MG; Solórzano-Santos F; Cabrera-Muñoz L; Díaz-Ponce H Bol Med Hosp Infant Mex; 1993 Sep; 50(9):662-5. PubMed ID: 8373548 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of functional liver derangement in visceral leishmaniasis at an Indian tertiary care center. Mathur P; Samantaray JC; Samanta P Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1170-2. PubMed ID: 18619918 [TBL] [Abstract][Full Text] [Related]
10. Epidemiological, clinical and therapeutic features of pediatric kala-azar. Rahim KM; Ashkan MM Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):626-30. PubMed ID: 17882998 [TBL] [Abstract][Full Text] [Related]
12. Liver biopsy in the diagnosis of visceral leishmaniasis. Artan R; Yilmaz A; Akçam M; Aksoy NH J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):299-302. PubMed ID: 16460490 [TBL] [Abstract][Full Text] [Related]
13. Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis. Makaritsis KP; Gatselis NK; Ioannou M; Petinaki E; Dalekos GN Int J Infect Dis; 2009 Jul; 13(4):e157-60. PubMed ID: 19008139 [TBL] [Abstract][Full Text] [Related]
14. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report. Toran KC; Sah SP; Joshi A; Rani S Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319 [TBL] [Abstract][Full Text] [Related]
15. [Syndrome of inappropriate macrophage activation associated with infantile visceral leishmaniasis]. Thabet F; Tabarki B; Fehem R; Yacoub M; Selmi H; Essoussi AS Tunis Med; 1999 Dec; 77(12):648-50. PubMed ID: 10730157 [TBL] [Abstract][Full Text] [Related]
16. Visceral leishmaniasis masquerading as myelodysplasia. Kopterides P; Halikias S; Tsavaris N Am J Hematol; 2003 Nov; 74(3):198-9. PubMed ID: 14587050 [TBL] [Abstract][Full Text] [Related]
17. A case of kala-azar diagnosed by bone marrow aspiration. Hamidah NH; Cheong SK; Abu Hassan J Malays J Pathol; 1995 Jun; 17(1):39-41. PubMed ID: 8907004 [TBL] [Abstract][Full Text] [Related]
18. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations. Ramesh V Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544 [No Abstract] [Full Text] [Related]
19. Visceral leishmaniasis simulating chronic liver disease: successful treatment with miltefosine. Avasthi R; Chaudhary SC; Khanna S Indian J Med Microbiol; 2009; 27(1):85-6. PubMed ID: 19172077 [No Abstract] [Full Text] [Related]
20. Acute liver failure: a rare clinical presentation of visceral leishmaniasis. Sagnelli C; Di Martino F; Coppola N; Crisci A; Sagnelli E New Microbiol; 2012 Jan; 35(1):93-5. PubMed ID: 22378560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]